Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7090593

Cc1cc([O-])ccc1N(C)C.Cc1cc([O-])ccc1N(C)C.Cc1cc([O-])ccc1N(C)C.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.[Al+3]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.35
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL27943511 0.76 ALDH1A1 (0.40) ESR1ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL6423662 0.76 ALDH1A1 (0.40) ESR1ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL7086263 0.74 ALDH1A1 (0.41) KDM4EALDH1A1PTGS1PTGS2
SCHEMBL19454665 0.66 PTGS2 (0.44) KDM4EALDH1A1HTTPTGS1PTGS2
Trifluoromethanesulfonic Acid SCHEMBL7089262 0.66 PTPN1 (0.47) PTGS1PTGS2
SCHEMBL170653 0.65 ESR1 (0.49) ESR1
Trifluoromethanesulfonic Acid SCHEMBL7655778 0.65 GPR3 (0.41) ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL6423653 0.65 ALDH1A1 (0.58) KDM4EALDH1A1HTT
Trifluoromethanesulfonic Acid SCHEMBL7089026 0.65 PTPN1 (0.35)
Sulfuric Acid SCHEMBL11315271 0.65 ESR1 (0.33) ESR1KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624321-B2 Metathesis ring-opening polymerization of cyclic ethers in the presence of catalysts such as aluminum bis(trifluoromethane-sulfonate) phenolate BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-20030097026-A1 Process for the preparation of polyether polyols DENNINGER UWE (DE) 2003-05-22 US disclosed
US-6492565-B2 USING ALKYLENE OXIDE IN PRESENCE OF LEWIS ACID CATALYST BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US disclosed
US-20010053866-A1 Process for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097026-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 ESR1 640/4885KDM4E 1896/4885ALDH1A1 3594/4885
US-20010053866-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 ESR1 640/4885KDM4E 1896/4885ALDH1A1 3594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.